Kanglong Chemical (300759.SZ) overseas subsidiary plans to participate in overseas equity investment funds for 10 million US dollars

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Kanglong Chemical (300759.SZ) announced that Kanglong UK, a wholly-owned subsidiary of the company, plans to participate in the investment of HJ Double Helix Fund L.P. (“Fund”) as a limited partner with a pledge of 10 million US dollars using its own or self-raised funds. On November 6, 2026, Kanglong UK signed a fund subscription document. According to this, it subscribes to the fund's limited partnership rights and is bound by the relevant provisions of the fund's “Partnership Agreement” and enjoys corresponding rights. The fund mainly makes equity and equity-related investments in the global biotechnology sector, focusing on nucleic acid drugs, cell and gene therapy, and investment opportunities in their upstream and/or downstream industries.